CN101198326B - Ⅱ型糖尿病治疗用的组合药物制剂 - Google Patents

Ⅱ型糖尿病治疗用的组合药物制剂 Download PDF

Info

Publication number
CN101198326B
CN101198326B CN2006800218679A CN200680021867A CN101198326B CN 101198326 B CN101198326 B CN 101198326B CN 2006800218679 A CN2006800218679 A CN 2006800218679A CN 200680021867 A CN200680021867 A CN 200680021867A CN 101198326 B CN101198326 B CN 101198326B
Authority
CN
China
Prior art keywords
medicine
voglibose
alpha
composition
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2006800218679A
Other languages
English (en)
Chinese (zh)
Other versions
CN101198326A (zh
Inventor
清野雄治
大久保吉男
本谷胜美
御子柴今雄
生岛一真
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kissei Pharmaceutical Co Ltd
Original Assignee
Kissei Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co Ltd filed Critical Kissei Pharmaceutical Co Ltd
Publication of CN101198326A publication Critical patent/CN101198326A/zh
Application granted granted Critical
Publication of CN101198326B publication Critical patent/CN101198326B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN2006800218679A 2005-04-20 2006-04-18 Ⅱ型糖尿病治疗用的组合药物制剂 Expired - Fee Related CN101198326B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP121862/2005 2005-04-20
JP2005121862 2005-04-20
JP166314/2005 2005-06-07
JP2005166314 2005-06-07
PCT/JP2006/308110 WO2006115115A1 (ja) 2005-04-20 2006-04-18 ２型糖尿病治療用の併用医薬

Publications (2)

Publication Number Publication Date
CN101198326A CN101198326A (zh) 2008-06-11
CN101198326B true CN101198326B (zh) 2011-10-12

Family

ID=37214736

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2006800218679A Expired - Fee Related CN101198326B (zh) 2005-04-20 2006-04-18 Ⅱ型糖尿病治疗用的组合药物制剂

Country Status (7)

Country Link
US (1) US7888382B2 (enExample)
EP (1) EP1872781A4 (enExample)
JP (3) JP4230524B2 (enExample)
KR (1) KR101380813B1 (enExample)
CN (1) CN101198326B (enExample)
CA (1) CA2605302A1 (enExample)
WO (1) WO2006115115A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101380813B1 (ko) * 2005-04-20 2014-04-04 깃세이 야쿠힌 고교 가부시키가이샤 2형 당뇨병 치료용 병용 의약
CN105296620B (zh) 2015-10-26 2019-01-15 上海市内分泌代谢病研究所 肠道宏基因组特征作为2型糖尿病阿卡波糖疗效筛选标志
JP7680822B2 (ja) * 2017-08-08 2025-05-21 日本ケミファ株式会社 糖尿病治療剤

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004002473A1 (ja) * 2002-06-28 2004-01-08 Kissei Pharmaceutical Co., Ltd. 血糖コントロール用医薬組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001234114A1 (en) 2000-02-24 2001-09-03 Takeda Chemical Industries Ltd. Drugs containing combined active ingredients
JP4917712B2 (ja) * 2000-02-24 2012-04-18 武田薬品工業株式会社 併用医薬
US6830759B2 (en) * 2002-06-28 2004-12-14 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
WO2004082621A2 (en) * 2003-03-15 2004-09-30 Bethesda Pharmaceuticals, Inc. Novel ppar agonists, pharmaceutical compositions and uses thereof
TW200521131A (en) * 2003-08-01 2005-07-01 Janssen Pharmaceutica Nv Substituted fused heterocyclic c-glycosides
WO2005082414A2 (en) * 2004-03-02 2005-09-09 Astellas Pharma Inc. Concomitant drugs of a sulfonamide and another therapeutic agent
KR101380813B1 (ko) * 2005-04-20 2014-04-04 깃세이 야쿠힌 고교 가부시키가이샤 2형 당뇨병 치료용 병용 의약
CN101325959A (zh) * 2005-09-14 2008-12-17 伊利舍医药品公司 用于受控碳水化合物消化的联合疗法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004002473A1 (ja) * 2002-06-28 2004-01-08 Kissei Pharmaceutical Co., Ltd. 血糖コントロール用医薬組成物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Kiyoshi Ichikawa, Kazuyasu Maruyama, Makoto Murakami,Atsutoshi Tsuji, Tokuhisa Yamato, Hiroshi Kusama, MasamiKojima.Absence of exacerbation of myocardial stunning inanesthetized dogs treated with KAD-1229, a novelhypoglycemic agent.European Journal of Pharmacologyvol. 431 no. 3.2001,vol. 431(no. 3),全文.
Kiyoshi Ichikawa, Kazuyasu Maruyama, Makoto Murakami,Atsutoshi Tsuji, Tokuhisa Yamato, Hiroshi Kusama, MasamiKojima.Absence of exacerbation of myocardial stunning inanesthetized dogs treated with KAD-1229, a novelhypoglycemic agent.European Journal of Pharmacologyvol. 431 no. 3.2001,vol. 431(no. 3),全文. *

Also Published As

Publication number Publication date
WO2006115115A1 (ja) 2006-11-02
JPWO2006115115A1 (ja) 2008-12-18
KR20070118163A (ko) 2007-12-13
KR101380813B1 (ko) 2014-04-04
US7888382B2 (en) 2011-02-15
JP4230524B2 (ja) 2009-02-25
EP1872781A1 (en) 2008-01-02
CA2605302A1 (en) 2006-11-02
CN101198326A (zh) 2008-06-11
US20090030063A1 (en) 2009-01-29
JP2008189679A (ja) 2008-08-21
JP2012092140A (ja) 2012-05-17
EP1872781A4 (en) 2009-04-01
JP5117230B2 (ja) 2013-01-16

Similar Documents

Publication Publication Date Title
CN105963296B (zh) 一种含有阿利沙坦酯或其盐或其水解产物或其水解产物盐的药物组合物及其用途
US11219594B2 (en) Effervescent compositions of metformin and processes for preparation thereof
TW201006488A (en) Use of ultrarapid acting insulin
TW200911275A (en) Pharmaceutical composition comprising a pyrazole-O-glucoside derivative
US20090169490A1 (en) Composition and method for weight loss
CN101181264A (zh) 一种以盐酸二甲双胍和维格列汀为活性成分的药用组合物及其制备方法、用途
CN101198326B (zh) Ⅱ型糖尿病治疗用的组合药物制剂
CN111840112B (zh) 鼠尾草酸或其衍生物在制备治疗糖尿病并发症药物中的应用
KR100709528B1 (ko) 혈당콘트롤용 의약조성물
CN103417971A (zh) 二肽基肽酶抑制剂和b族维生素的药物组合物及用途
US20210077430A1 (en) Combination therapy
CN103230594A (zh) α-葡萄糖苷酶抑制剂和B族维生素的药物组合物
US9061061B2 (en) Method of treating dysglycemia and glucose excursions
Fowler DIABETES FOUNDATION. Diabetes Treatment: Oral Agents.
CN104906114A (zh) 一种二甲双胍格列喹酮复方缓释胶囊及制备方法
US9737559B2 (en) Synergistic anti-diabetic compositions
CN103222966A (zh) 一种含有盐酸芬戈莫德的固体药物组合物及其制备方法
CN112641776A (zh) 一种以二甲双胍或其可药用盐和澳格列汀或其可药用盐为活性成分的药用组合物
KR100709531B1 (ko) 당뇨병성 합병증의 예방 또는 진전저지용 의약조성물
CN103599540B (zh) 含有格列奈类药物和b族维生素的药物组合物及其用途
CN116983301A (zh) 一种沙库巴曲缬沙坦钠药物组合物及其制备方法和用途
Tablets et al. Pr SANDOZ SAXAGLIPTIN
MX2012014757A (es) Composicion farmaceutica de una meglitinida y una tiazolidinediona o sus sales farmaceuticamente aceptables y su uso.
CN107595863A (zh) 一种用于降低血糖血脂的药物复方制剂及其用途
HK1143067A (en) Pharmaceutical composition for treating dysglycemia and glucose excursions

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20111012

Termination date: 20210418